Zhou, Q., Lv, H., Mazloom, A. R., Xu, H., Ma'ayan, A., & Gallo, J. M. (2012). Activation of Alternate Prosurvival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts. The American Society for Pharmacology and Experimental Therapeutics.

Zhou, Qingyu, Hua Lv, Amin R. Mazloom, Huilei Xu, Avi Ma'ayan, et James M. Gallo. Activation of Alternate Prosurvival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts. The American Society for Pharmacology and Experimental Therapeutics, 2012.

Zhou, Qingyu, et al. Activation of Alternate Prosurvival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts. The American Society for Pharmacology and Experimental Therapeutics, 2012.